MiRNA Deregulation Distinguishes Anaplastic Thyroid Carcinoma (ATC) and Supports Upregulation of Oncogene Expression.

Misiak, Danny; Bauer, Marcus; Lange, Jana; Haase, Jacob; Braun, Juliane; Lorenz, Kerstin; Wickenhauser, Claudia; Hüttelmaier, Stefan

Misiak, Danny; Bauer, Marcus; Lange, Jana; Haase, Jacob; Braun, Juliane; Lorenz, Kerstin; Wickenhauser, Claudia; Hüttelmaier, Stefan.

Afiliación

Misiak D; Institute of Molecular Medicine, Martin Luther University Halle-Wittenberg, 06120 Halle, Germany.
Bauer M; Institute of Pathology, Martin Luther University Halle-Wittenberg, 06112 Halle, Germany.
Lange J; Institute of Molecular Medicine, Martin Luther University Halle-Wittenberg, 06120 Halle, Germany.
Haase J; Institute of Molecular Medicine, Martin Luther University Halle-Wittenberg, 06120 Halle, Germany.
Braun J; Division of Endocrinology, Diabetes, and Hypertension, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
Lorenz K; Institute of Molecular Medicine, Martin Luther University Halle-Wittenberg, 06120 Halle, Germany.
Wickenhauser C; Merck KGaA, 64293 Darmstadt, Germany.
Hüttelmaier S; Department of Visceral, Vascular, and Endocrine Surgery, Martin Luther University Halle-Wittenberg, 06120 Halle, Germany.

Cancers (Basel) ; 13(23)2021 Nov 24.

Article en En | MEDLINE | ID: mdl-34885022

Palabras clave

ATC; diagnostic marker; miRNAs; microRNA-target interaction; microRNAs; thyroid cancer

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Cancers (Basel) Año: 2021 Tipo del documento: Article País de afiliación: Alemania

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google